{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T02:11:20Z","timestamp":1770948680862,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,12]]},"DOI":"10.7759\/cureus.103499","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T01:26:46Z","timestamp":1770946006000},"source":"Crossref","is-referenced-by-count":0,"title":["Spontaneous Massive Hemorrhage Caused by Inflammatory Myofibroblastic Tumor (IMT) of the Greater Omentum: A Case Report"],"prefix":"10.7759","author":[{"given":"Wanbin","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5603\/ARM.2018.0007","article-title":"Inflammatory myofibroblastic tumor of the lung","volume":"86","author":"Khatri A","year":"2018","unstructured":"Khatri A, Agrawal A, Sikachi RR, Mehta D, Sahni S, Meena N. Inflammatory myofibroblastic tumor of the lung. Adv Respir Med. 2018, 86:27-35. 10.5603\/ARM.2018.0007","journal-title":"Adv Respir Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17081327","article-title":"Inflammatory myofibroblastic tumor: sn updated review","volume":"17","author":"Choi JH","year":"2025","unstructured":"Choi JH. Inflammatory myofibroblastic tumor: sn updated review. Cancers (Basel). 2025, 17:1327. 10.3390\/cancers17081327","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.32604\/or.2024.050350","article-title":"Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment","volume":"32","author":"Chmiel P","year":"2024","unstructured":"Chmiel P, S\u0142OW A, Banaszek \u0141, et al.. Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment. Oncol Res. 2024, 32:1141-62. 10.32604\/or.2024.050350","journal-title":"Oncol Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.84811","article-title":"Pulmonary inflammatory myofibroblastic tumor in a patient treated for pemphigus vulgaris: a case report","volume":"17","author":"Rhazari M","year":"2025","unstructured":"Rhazari M, Thouil A, Gartini S, Kouismi H, Lakhal M. Pulmonary inflammatory myofibroblastic tumor in a patient treated for pemphigus vulgaris: a case report. Cureus. 2025, 17:e84811. 10.7759\/cureus.84811","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Revised Surgical CAse REport (SCARE) Guideline. An update for the age of artificial intelligence. (2025). Accessed: September 24, 2025: https:\/\/doi.org\/10.70389\/PJS.100079.","DOI":"10.70389\/PJS.100079"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33618","article-title":"Ultra-rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities","volume":"127","author":"Stacchiotti S","year":"2021","unstructured":"Stacchiotti S, Frezza AM, Blay JY, et al.. Ultra-rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer. 2021, 127:2934-42. 10.1002\/cncr.33618","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000284","article-title":"The 2020 WHO classification of tumors of soft tissue: selected changes and new entities","volume":"28","author":"Choi JH","year":"2021","unstructured":"Choi JH, Ro JY. The 2020 WHO classification of tumors of soft tissue: selected changes and new entities. Adv Anat Pathol. 2021, 28:44-58. 10.1097\/PAP.0000000000000284","journal-title":"Adv Anat Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3934\/mbe.2019339","article-title":"Inflammatory myofibroblastic tumor: a demographic, clinical and therapeutic study of 92 cases","volume":"16","author":"Fu GX","year":"2019","unstructured":"Fu GX, Xu CC, Yao NF, Gu JZ, Jiang HL, Han XF. Inflammatory myofibroblastic tumor: a demographic, clinical and therapeutic study of 92 cases. Math Biosci Eng. 2019, 16:6794-804. 10.3934\/mbe.2019339","journal-title":"Math Biosci Eng"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02343-3","article-title":"Clinical diagnosis and treatment of abdominal inflammatory myofibroblastic tumors","volume":"16","author":"Zhang Q","year":"2025","unstructured":"Zhang Q, Zhang ZW, Fan J, Ji ZM, Wang CY, Liu F. Clinical diagnosis and treatment of abdominal inflammatory myofibroblastic tumors. Discov Oncol. 2025, 16:554. 10.1007\/s12672-025-02343-3","journal-title":"Discov Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2016150191","article-title":"Pediatric fibroblastic and myofibroblastic tumors: a pictorial review","volume":"36","author":"Sargar KM","year":"2016","unstructured":"Sargar KM, Sheybani EF, Shenoy A, Aranake-Chrisinger J, Khanna G. Pediatric fibroblastic and myofibroblastic tumors: a pictorial review. Radiographics. 2016, 36:1195-214. 10.1148\/rg.2016150191","journal-title":"Radiographics"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcl.2015.12.005","article-title":"Inflammatory myofibroblastic tumors: current update","volume":"54","author":"Surabhi VR","year":"2016","unstructured":"Surabhi VR, Chua S, Patel RP, Takahashi N, Lalwani N, Prasad SR. Inflammatory myofibroblastic tumors: current update. Radiol Clin North Am. 2016, 54:553-63. 10.1016\/j.rcl.2015.12.005","journal-title":"Radiol Clin North Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2018180192","article-title":"Primary lung tumors in children: radiologic-pathologic correlation from the radiologic pathology archives","volume":"38","author":"Lichtenberger JP 3rd","year":"2018","unstructured":"Lichtenberger JP 3rd, Biko DM, Carter BW, Pavio MA, Huppmann AR, Chung EM. Primary lung tumors in children: radiologic-pathologic correlation from the radiologic pathology archives. Radiographics. 2018, 38:2151-72. 10.1148\/rg.2018180192","journal-title":"Radiographics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15054","article-title":"Hepatic inflammatory pseudotumor mimicking malignant tumor with rare onset of Intra-abdominal hemorrhage","volume":"41","author":"Yamamura K","year":"2021","unstructured":"Yamamura K, Beppu T, Oda E, et al.. Hepatic inflammatory pseudotumor mimicking malignant tumor with rare onset of Intra-abdominal hemorrhage. Anticancer Res. 2021, 41:2727-32. 10.21873\/anticanres.15054","journal-title":"Anticancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5679634","article-title":"The clinical and radiological characteristics of inflammatory myofibroblastic tumor occurring at unusual sites","volume":"2018","author":"Zeng X","year":"2018","unstructured":"Zeng X, Huang H, Li J, Peng J, Zhang J. The clinical and radiological characteristics of inflammatory myofibroblastic tumor occurring at unusual sites. Biomed Res Int. 2018, 2018:5679634. 10.1155\/2018\/5679634","journal-title":"Biomed Res Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59359","article-title":"Inflammatory myofibroblastic tumor after receiving treatment for non-small cell carcinoma","volume":"16","author":"Parker NC","year":"2024","unstructured":"Parker NC, Singanallur P, Faiek S, Gao J, White P. Inflammatory myofibroblastic tumor after receiving treatment for non-small cell carcinoma. Cureus. 2024, 16:e59359. 10.7759\/cureus.59359","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153662","article-title":"Inflammatory myofibroblastic tumour: state of the art","volume":"14","author":"Gros L","year":"2022","unstructured":"Gros L, Dei Tos AP, Jones RL, Digklia A. Inflammatory myofibroblastic tumour: state of the art. Cancers (Basel). 2022, 14:3662. 10.3390\/cancers14153662","journal-title":"Cancers (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.70027","article-title":"Chinese expert consensus on the diagnosis and treatment of inflammatory myofibroblastic tumor","volume":"16","author":"Si X","year":"2025","unstructured":"Si X, Wu S, Feng R, et al.. Chinese expert consensus on the diagnosis and treatment of inflammatory myofibroblastic tumor. Thorac Cancer. 2025, 16:e70027. 10.1111\/1759-7714.70027","journal-title":"Thorac Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2025.02.005","article-title":"Insights into inflammatory myofibroblastic tumor: a complex and challenging diagnosis","volume":"20","author":"Arshad H","year":"2025","unstructured":"Arshad H, Crawford CK, Fishman EK. Insights into inflammatory myofibroblastic tumor: a complex and challenging diagnosis. Radiol Case Rep. 2025, 20:2468-71. 10.1016\/j.radcr.2025.02.005","journal-title":"Radiol Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-018-1161-0","article-title":"Clinical and histopathologic correlates and management strategies for inflammatory myofibroblastic tumor of the lung. A case series and review of the literature","volume":"35","author":"Sagar AE","year":"2018","unstructured":"Sagar AE, Jimenez CA, Shannon VR. Clinical and histopathologic correlates and management strategies for inflammatory myofibroblastic tumor of the lung. A case series and review of the literature. Med Oncol. 2018, 35:102. 10.1007\/s12032-018-1161-0","journal-title":"Med Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007056","article-title":"Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor","volume":"363","author":"Butrynski JE","year":"2010","unstructured":"Butrynski JE, D'Adamo DR, Hornick JL, et al.. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010, 363:1727-33. 10.1056\/NEJMoa1007056","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/460053-spontaneous-massive-hemorrhage-caused-by-inflammatory-myofibroblastic-tumor-imt-of-the-greater-omentum-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T01:26:47Z","timestamp":1770946007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/460053-spontaneous-massive-hemorrhage-caused-by-inflammatory-myofibroblastic-tumor-imt-of-the-greater-omentum-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.103499","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,12]]}}}